Test Price
2,800 AED✅ Home Collection Available
HYDIN Gene Primary Ciliary Dyskinesia Type 5 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee
99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
Premium Logistics
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection. Available daily from 8 AM to 11 PM.
Clinical Guidance
Telephonic Post-Test Clinical Guidance in result interpretation included.
Insurance Verification
Direct Billing Verification via WhatsApp: +971 54 548 8731.
This genetic test examines the HYDIN gene for pathogenic variants causing Primary Ciliary Dyskinesia type 5 (PCD), an autosomal recessive disorder affecting respiratory cilia function. Dual-verified Next-Generation Sequencing (NGS) aligned with DHA protocols delivers results within 3–4 weeks with 99.9% analytic sensitivity. The all-inclusive price of 2,800 AED covers home collection, pre-test genetic counselling, and post-test clinical guidance. All health data is protected under UAE Personal Data Protection Law and associated health information regulations.
Test Overview & Methodology
The HYDIN gene test screens for mutations associated with Primary Ciliary Dyskinesia type 5 using whole-gene Next-Generation Sequencing with copy number variant analysis. This comprehensive approach detects over 99% of pathogenic variants, including deep intronic mutations and large deletions that single-gene Sanger sequencing routinely misses. Clinical correlation with nasal nitric oxide measurements, high-speed video microscopy, and a detailed respiratory history is essential for definitive diagnosis. Pre-test genetic counselling is mandatory to confirm the inheritance pattern and establish a complete pedigree.
| Feature | Our Test (NGS) | Closest Alternative |
|---|---|---|
| Method | Full HYDIN gene NGS + CNV analysis | Single-gene Sanger sequencing or limited panel |
| Detection Rate | Over 99% of pathogenic variants | Approximately 85-90%, missing deep intronic and CNV events |
| Turnaround | 3-4 weeks | 6-12 weeks |
| UAE Compliance | DHA, ISO 9001:2015, PDPL, Health ICT Law | Varies; often lacks local regulatory approval |
Physician Insight & Safety Protocols
“A genetic finding involving the HYDIN gene provides valuable diagnostic information, yet it must always be correlated with functional studies such as nasal nitric oxide levels and ciliary beat pattern analysis. The comprehensive NGS approach we employ captures the full spectrum of variants, including those in non-coding regions that standard panels might overlook. I strongly recommend attending the mandatory pre-test counselling session and the post-test consultation so we can integrate the molecular data with your complete clinical picture.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice
Do not alter or discontinue any prescribed treatments without consulting your doctor. This genetic test is intended for diagnostic clarification and does not replace your current management plan. All sample collection procedures follow strict safety protocols governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Exclusion Criteria & Emergency Indicators
- Exclusion Criteria: Active severe respiratory infection, inability to provide informed consent, or failure to complete mandatory pre-test genetic counselling.
- Seek Emergency Care Immediately If: You experience sudden shortness of breath, cyanosis (blue lips or skin), sharp chest pain, or confusion. These symptoms may indicate a medical complication requiring urgent attention and are not directly related to the genetic test procedure.
Patient FAQ & Clinical Guidance
1. What is the HYDIN gene test used for?
Direct Answer: This test diagnoses Primary Ciliary Dyskinesia type 5 by detecting pathogenic mutations in the HYDIN gene using whole-gene next-generation sequencing, enabling precise medical management and genetic counselling.
2. How accurate is this genetic test compared to older methods?
Direct Answer: The NGS assay delivers over 99% sensitivity and specificity for HYDIN variants, significantly outperforming single-exon Sanger sequencing which misses 10-15% of causative mutations including deep intronic changes and copy number variants.
3. What sample types are accepted and is fasting needed?
Direct Answer: We accept whole blood (EDTA tube), extracted DNA, or a dried blood spot on an FTA card. No fasting or medication adjustments are required before sample collection. Home collection via temperature-controlled cold-chain courier is available daily from 8 AM to 11 PM.
4. How long does it take to get results?
Direct Answer: Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. You will receive a telephone call from our clinical genetics team to discuss the findings and their implications.
5. What pre-test preparation is required?
Direct Answer: A mandatory pre-test genetic counselling session is required via teleconsultation to draw a pedigree chart and confirm the inheritance pattern. A documented clinical history of recurrent respiratory infections, neonatal respiratory distress, chronic otitis media, or infertility is recommended.
UAE Regulatory & Data Privacy Adherence
Your genetic data is processed under the full protection of Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genomic and clinical information is encrypted, stored securely within the UAE, and never shared with third parties without your explicit consent. Clinical testing safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE operates under DHA Facility License Number 1143 and is ISO 9001:2015 accredited.
Clinical & Logistical Metadata
| Test Name | HYDIN Gene Primary Ciliary Dyskinesia Type 5 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3-4 Weeks (10-14 Business Days) |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card). VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available. |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV Analysis, ISO 9001:2015 Accredited |
| ICD-10-CM Code | J98.09 (Primary Ciliary Dyskinesia) |
| LOINC Code | 21636-6 (Genetic analysis report) |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians